A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Abroad (travel likely)Recruiting

Conditions

Appendiceal Adenocarcinoma · Colorectal

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Michael White, MD) · mgwhite@mdanderson.org · 713-355-0897
Contact: Principal Investigator (Michael White, MD)

Study leads

Michael White, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Colorectal Cancer · Cholangiocarcinoma · Appendiceal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · Irvine, United States

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

Appendiceal Cancer · Colorectal Adenocarcinoma · Peritoneal Metastases

Abroad (travel likely)Recruiting

New Haven, United States

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

Metastatic Appendiceal Adenocarcinoma · Intraperitoneal Paclitaxel

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Small Bowel Cancer · Colorectal Cancer · Appendiceal Cancer

Abroad (travel likely)Recruiting

Sacramento, United States